Biotech Company Rubius Therapeutics Finalizes Deal to Have Manufacturing Facility in RI

GoLocalProv Business Team

Biotech Company Rubius Therapeutics Finalizes Deal to Have Manufacturing Facility in RI

Rubius Therapeutics set to establish manufacturing facility in RI. PHOTO: Rubius Therapeutics
The biotechnology company Rubius Therapeutics has finalized a deal to establish a manufacturing facility in Rhode Island.

The company plans to invest as much as $155 million over a five-year period to renovate a 135,000 square foot manufacturing facility in Smithfield. Rubius takes over the facility which was formerly Alexion. That company closed the RI facility in September of 2017 jettisoning 250 positions.

The facility is expected to create 160 jobs in manufacturing, biotech operations, and other support functions.

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

"This is more outstanding news for Rhode Island. I'm thrilled that Rubius has decided to invest here, adding to the growing list of companies bringing highly-skilled jobs to our state. There are more jobs in Rhode Island than ever before, and we're continuing to make progress. Today's announcement is more proof that our approach is working,” said Governor Gina Raimondo.

The plan was originally announced in June. 

Incentives for Rubius

The facility will be supported by incentives from Rhode Island’s innovative toolkit of economic development programs.

The Board of the Rhode Island Commerce Corporation approved tax credits through the Rebuild Rhode Island Tax Credit Program and the Qualified Jobs Incentive Act.

The estimated value of the Rebuild Rhode Island Tax Credit is approximately $2.75 million. The estimated value of the Qualified Jobs tax credits is approximately $370,000 per year over 10 years.

The credits will be paid out after the jobs are created and employees have paid income tax for a full year.

The company will also be eligible for a sales tax rebate on construction materials.

R.I. Secretary of Commerce Stefan Pryor added, "We are very pleased that Rubius Therapeutics is bringing its new advanced manufacturing facility to Rhode Island. Rubius joins companies such as Amgen, Johnson & Johnson, and EpiVax in our flourishing bioscience ecosystem. We thank Rubius for choosing Rhode Island and look forward to the company's success here."


Some of the Most Interesting GoLocal LIVE Interviews -- The First 1,000

Enjoy this post? Share it with others.